Pancreatic Cancer Research

Clinical trialObservationalUnknown

Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan

Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version of the EORTC QLQ-PAN26 and EORTC QLQ-C30 in Taiwan

Outcome
Outcome unknown
Phase
Observational
Status
Unknown
Study type
Observational
Start
22 November 2021
Listed end
22 November 2024
Enrollment
300 participants
Sites
1
Primary outcomes
Quality of Life (EORTC QLQ-C30 ); Quality of Life (EORTC QLQ-PAN26 ); Quality of Life (EORTC QLQ-PAN26 ); Quality of Life(SF-36)
Sponsor type
Other government
Results posted
No
Last update
14 November 2023

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study will investigate the reliability and validity of Chinese version of the quality of life scale in EORTC QLQ-PAN26 and EORTC QLQ-C30 on pancreatic cancer patients in Taiwan

Detailed description public domain (ClinicalTrials.gov)

1. Verify the reliability and validity of Chinese version of the EORTC QLQ-C30 Quality of Life Scale and the chinese version of the EORTC QLQ-PAN26 Quality of Life Scale. 2. Verify the construct validity of the Chinese version of the EORTC QLQ-PAN26 Quality of Life Scale, perform factor analysis, test-retest reliability, and known group validity 3. Verify the criterion related validity of Chinese version of the EORTC QLQ-C30 Quality of Life Scale and the SF-36 Quality of Life Scale